Delivery Order SPE2DB22D1103-SPE2DB25FTRW0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with a completion date of June 24, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a $4,306.80 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,460.20 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger relationship with DLA. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order valued at $7,227 to AmerisourceBergen Drug Corp for BOTOX 200 unit vials, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTRW0Delivery Order
The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials, with an ultimate completion date of August 4, 2025. This is a non-set-aside contract awarded competitively to the pharmaceutical distributor's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within AmerisourceBergen's broader federal contract portfolio and supports the military healthcare supply chain's pharmaceutical procurement needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, medical devices, vaccines, and specialized healthcare commodities to military healthcare systems worldwide. AmerisourceBergen's track record of competitively awarded contracts with DLA demonstrates its established capability to fulfill federal medical supply requirements, positioning the company as a critical vendor for Defense Health Agency and other government healthcare system needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/14/25 |